Tokyo - Sosei Group Corporation ('the Company'; TSE: 4565) today announces the appointment of Mr. Rolf Soderstrom as a new Board Director and the promotion of Dr. Malcolm Weir to Executive Vice Chairman.

These changes, which were announced at the Company's 30th Shareholders' Meeting held in Tokyo today, alongside the completion of a realignment of its UK R&D organization in which a number of talented scientists were promoted, have been designed to strengthen the focus of Sosei Heptares on the execution of the next stage of the Company's growth strategy. This strategy aims to leverage Sosei Heptares' world-class Platform, Discovery and Early Development capabilities with a focus on advancing and extending its portfolio of Partnered Programs.

Details of the changes are as follows

Board of Directors (effective 25 March 2020)

Chairman of the Board Shinichi Tamura (reappointed)

External Director

Tomohiro Tohyama (reappointed)

External Independent Director Kuniaki Kaga (reappointed)

External Independent Director David Roblin (reappointed)

External Independent Director Noriaki Nagai (reappointed)

External Independent Director Rolf Soderstrom (newly appointed)

Mr. Rolf Soderstrom is a newly appointed External Director. He brings over 30 years' experience in finance and a track record of accelerating the profitable growth of companies and delivering shareholder returns. Rolf has extensive strategic, operational and international experience including M&A, fundraisings and disposals. He was previously CFO at the UK-listed FTSE250 specialist healthcare company BTG plc (2008-2018), which was acquired by Boston Scientific for US$4.2 billion in 2019. Before that, Rolf was Divisional Finance Director at Cobham Plc and a Director of Corporate Finance at Cable & Wireless Plc. He qualified as a chartered accountant at PricewaterhouseCoopers.

Rolf's appointment follows the retirement of Mrs. Julia Gregory from the Sosei Group Board of Directors at today's Shareholders' meeting.

Chairman, President and Chief Executive Officer, Shinichi Tamura said: 'On behalf of the Board and the Company's key stakeholders I would to like to thank Julia for her important contribution to the growth and development of the Group over the past three years. I would also like to welcome Rolf, whose financial and operational experience in the global biotech industry will be invaluable as we continue to deliver on our internationally focused growth strategy.'

Contact:

Tel: +81-(0)3-5210-3290

Fax: +81-(0)3-5210-3291

(C) 2020 Electronic News Publishing, source ENP Newswire